Phentermine And Topiramate 11014-0756
Product NDC
11014-0756- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule, Extended Release
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CIV
- Marketing Start
- January 1, 2024
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Phentermine Hydrochloride | 18.66 mg/1 |
| Topiramate | 92 mg/1 |
Packaging Options(1)
1 BAG in 1 CONTAINER (11014-0756-1) / 70902 CAPSULE, EXTENDED RELEASE in 1 BAG